High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 180, Issue 3, Pages 383-392
Publisher
Wiley
Online
2015-01-21
DOI
10.1111/cei.12590
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells
- (2014) Tilman Schneider-Hohendorf et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis
- (2013) J. Sellner et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Structural Determinants of Unique Properties of Human IgG4-Fc
- (2013) Anna M. Davies et al. JOURNAL OF MOLECULAR BIOLOGY
- Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases
- (2013) M. C. Kowarik et al. JOURNAL OF NEUROLOGY
- Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients
- (2013) Samantha Jilek et al. Multiple Sclerosis Journal
- L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
- (2013) N. Schwab et al. NEUROLOGY
- Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
- (2012) Luisa M. Villar ARCHIVES OF NEUROLOGY
- Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases
- (2012) Katherine M. Mullen et al. JOURNAL OF NEUROIMMUNOLOGY
- Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
- (2012) A Harrer et al. Multiple Sclerosis Journal
- Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple Sclerosis
- (2012) Andrea Harrer et al. PLoS One
- Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody
- (2011) Theo Rispens et al. ANALYTICAL BIOCHEMISTRY
- Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE
- (2011) Veit Rothhammer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells
- (2011) Andrea Harrer et al. JOURNAL OF NEUROIMMUNOLOGY
- CD49d expression as a promising biomarker to monitor natalizumab efficacy
- (2011) Gilles Defer et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped
- (2011) Theo Rispens et al. Multiple Sclerosis Journal
- Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients
- (2011) Felipe von Glehn et al. Multiple Sclerosis Journal
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment
- (2010) P Wipfler et al. Multiple Sclerosis Journal
- Features of intrathecal immunoglobulins in patients with multiple sclerosis
- (2009) Franziska Di Pauli et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
- (2008) Maria del Pilar Martin ARCHIVES OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started